Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Operations: 2021-2024

Historic Cash from Operations for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$10.3 million.

  • Biofrontera's Cash from Operations fell 202.79% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year increase of 33.96%. This contributed to the annual value of -$10.3 million for FY2024, which is 58.63% up from last year.
  • As of FY2024, Biofrontera's Cash from Operations stood at -$10.3 million, which was up 58.63% from -$24.9 million recorded in FY2023.
  • Biofrontera's Cash from Operations' 5-year high stood at -$10.3 million during FY2024, with a 5-year trough of -$26.7 million in FY2021.
  • Moreover, its 3-year median value for Cash from Operations was -$16.2 million (2022), whereas its average is -$17.1 million.
  • Per our database at Business Quant, Biofrontera's Cash from Operations tumbled by 53.70% in 2023 and then skyrocketed by 58.63% in 2024.
  • Over the past 4 years, Biofrontera's Cash from Operations (Yearly) stood at -$26.7 million in 2021, then skyrocketed by 39.36% to -$16.2 million in 2022, then plummeted by 53.70% to -$24.9 million in 2023, then surged by 58.63% to -$10.3 million in 2024.